S&P 500   3,991.21 (+1.00%)
DOW   32,525.65 (+0.87%)
QQQ   308.23 (+0.74%)
AAPL   157.69 (+0.18%)
MSFT   273.63 (+0.51%)
META   200.91 (+1.57%)
GOOGL   101.61 (+0.39%)
AMZN   98.38 (+0.69%)
TSLA   188.86 (+3.06%)
NVDA   262.23 (+1.25%)
NIO   9.20 (+5.14%)
BABA   82.76 (+2.17%)
AMD   98.95 (+2.21%)
T   18.66 (+0.92%)
F   11.55 (+3.31%)
MU   59.30 (+2.88%)
CGC   1.95 (+4.84%)
GE   91.54 (+1.80%)
DIS   95.52 (+1.38%)
AMC   4.41 (+3.28%)
PFE   40.81 (+0.00%)
PYPL   74.96 (+2.39%)
NFLX   302.75 (-0.78%)
S&P 500   3,991.21 (+1.00%)
DOW   32,525.65 (+0.87%)
QQQ   308.23 (+0.74%)
AAPL   157.69 (+0.18%)
MSFT   273.63 (+0.51%)
META   200.91 (+1.57%)
GOOGL   101.61 (+0.39%)
AMZN   98.38 (+0.69%)
TSLA   188.86 (+3.06%)
NVDA   262.23 (+1.25%)
NIO   9.20 (+5.14%)
BABA   82.76 (+2.17%)
AMD   98.95 (+2.21%)
T   18.66 (+0.92%)
F   11.55 (+3.31%)
MU   59.30 (+2.88%)
CGC   1.95 (+4.84%)
GE   91.54 (+1.80%)
DIS   95.52 (+1.38%)
AMC   4.41 (+3.28%)
PFE   40.81 (+0.00%)
PYPL   74.96 (+2.39%)
NFLX   302.75 (-0.78%)
S&P 500   3,991.21 (+1.00%)
DOW   32,525.65 (+0.87%)
QQQ   308.23 (+0.74%)
AAPL   157.69 (+0.18%)
MSFT   273.63 (+0.51%)
META   200.91 (+1.57%)
GOOGL   101.61 (+0.39%)
AMZN   98.38 (+0.69%)
TSLA   188.86 (+3.06%)
NVDA   262.23 (+1.25%)
NIO   9.20 (+5.14%)
BABA   82.76 (+2.17%)
AMD   98.95 (+2.21%)
T   18.66 (+0.92%)
F   11.55 (+3.31%)
MU   59.30 (+2.88%)
CGC   1.95 (+4.84%)
GE   91.54 (+1.80%)
DIS   95.52 (+1.38%)
AMC   4.41 (+3.28%)
PFE   40.81 (+0.00%)
PYPL   74.96 (+2.39%)
NFLX   302.75 (-0.78%)
S&P 500   3,991.21 (+1.00%)
DOW   32,525.65 (+0.87%)
QQQ   308.23 (+0.74%)
AAPL   157.69 (+0.18%)
MSFT   273.63 (+0.51%)
META   200.91 (+1.57%)
GOOGL   101.61 (+0.39%)
AMZN   98.38 (+0.69%)
TSLA   188.86 (+3.06%)
NVDA   262.23 (+1.25%)
NIO   9.20 (+5.14%)
BABA   82.76 (+2.17%)
AMD   98.95 (+2.21%)
T   18.66 (+0.92%)
F   11.55 (+3.31%)
MU   59.30 (+2.88%)
CGC   1.95 (+4.84%)
GE   91.54 (+1.80%)
DIS   95.52 (+1.38%)
AMC   4.41 (+3.28%)
PFE   40.81 (+0.00%)
PYPL   74.96 (+2.39%)
NFLX   302.75 (-0.78%)
NYSE:CLB

Core Laboratories - CLB Stock Forecast, Price & News

$21.30
+0.55 (+2.65%)
(As of 03/21/2023 09:44 AM ET)
Add
Compare
Today's Range
$21.12
$21.74
50-Day Range
$20.08
$26.55
52-Week Range
$13.19
$34.08
Volume
17,844 shs
Average Volume
364,600 shs
Market Capitalization
$993.22 million
P/E Ratio
51.95
Dividend Yield
0.19%
Price Target
$21.83

Core Laboratories MarketRank™ Forecast

Analyst Rating
Hold
1.50 Rating Score
Upside/​Downside
5.2% Upside
$21.83 Price Target
Short Interest
Bearish
8.00% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.75mentions of Core Laboratories in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
36.25%
From $0.80 to $1.09 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.78 out of 5 stars

Oils/Energy Sector

211th out of 243 stocks

Oil & Gas Field Services, Not Elsewhere Classified Industry

17th out of 20 stocks


CLB stock logo

About Core Laboratories (NYSE:CLB) Stock

Core Laboratories NV engages in the provision of proprietary and patented reservoir description, production enhancement, and reservoir management services to the oil and gas industry. It operates through the Reservoir Description segment and Production Enhancement segment. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid, and gas samples and provides analytical and field services to characterize properties of crude oil and petroleum products. The Production Enhancement segment provides products and services relating to reservoir well completions, perforations, stimulations, and production. The company was founded in 1936 and is headquartered in Amsterdam, the Netherlands.

Receive CLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter.

CLB Stock News Headlines

Lithium Could Be 2023's Next Big Surprise
Lithium is the hottest commodity for our green future
Core Laboratories (CLB) Q4 2022 Earnings Call Transcript
Lithium Could Be 2023's Next Big Surprise
Lithium is the hottest commodity for our green future
Core Laboratories (CLB) Surpasses Q4 Earnings Estimates
Core Laboratories's Earnings: A Preview
Core Laboratories To Redomesticate To US
Why Core Laboratories (CLB) Stock Is Down Today
See More Headlines
Receive CLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter.

CLB Company Calendar

Last Earnings
2/02/2023
Ex-Dividend for 3/6 Dividend
2/10/2023
Dividend Payable
3/06/2023
Today
3/21/2023
Next Earnings (Estimated)
4/26/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Oil & gas field services, not elsewhere classified
Sub-Industry
N/A
Fax
N/A
Employees
3,600
Year Founded
1936

Price Target and Rating

Average Stock Price Forecast
$21.83
High Stock Price Forecast
$26.00
Low Stock Price Forecast
$20.00
Forecasted Upside/Downside
+5.2%
Consensus Rating
Hold
Rating Score (0-4)
1.50
Research Coverage
4 Analysts

Profitability

Net Income
$19.45 million
Pretax Margin
6.12%

Debt

Sales & Book Value

Annual Sales
$489.73 million
Cash Flow
$0.97 per share
Book Value
$4.07 per share

Miscellaneous

Free Float
46,438,000
Market Cap
$967.57 million
Optionable
Optionable
Beta
2.65

Social Links


Key Executives

  • Lawrence V. Bruno
    Chairman-Supervisory Board, President & CEO
  • Christopher S. Hill
    Chief Financial Officer & Senior Vice President
  • Mark Damian Tattoli
    Secretary, Senior Vice President & General Counsel
  • Kevin G. Daniels
    Treasurer, Chief Accounting Officer & VP
  • Jacobus Schouten
    Managing Director













CLB Stock - Frequently Asked Questions

Should I buy or sell Core Laboratories stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 2 sell ratings and 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CLB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLB, but not buy additional shares or sell existing shares.
View CLB analyst ratings
or view top-rated stocks.

What is Core Laboratories' stock price forecast for 2023?

4 Wall Street research analysts have issued 1-year target prices for Core Laboratories' stock. Their CLB share price forecasts range from $20.00 to $26.00. On average, they predict the company's stock price to reach $21.83 in the next twelve months. This suggests a possible upside of 5.2% from the stock's current price.
View analysts price targets for CLB
or view top-rated stocks among Wall Street analysts.

How have CLB shares performed in 2023?

Core Laboratories' stock was trading at $20.27 on January 1st, 2023. Since then, CLB shares have increased by 2.4% and is now trading at $20.75.
View the best growth stocks for 2023 here
.

When is Core Laboratories' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 26th 2023.
View our CLB earnings forecast
.

How were Core Laboratories' earnings last quarter?

Core Laboratories (NYSE:CLB) announced its quarterly earnings results on Thursday, February, 2nd. The oil and gas company reported $0.20 EPS for the quarter, topping analysts' consensus estimates of $0.19 by $0.01. The oil and gas company had revenue of $127.57 million for the quarter, compared to analysts' expectations of $130.12 million. Core Laboratories had a net margin of 3.97% and a trailing twelve-month return on equity of 15.98%. Core Laboratories's revenue was up 1.9% on a year-over-year basis. During the same period last year, the firm earned $0.20 earnings per share.

How often does Core Laboratories pay dividends? What is the dividend yield for Core Laboratories?

Core Laboratories declared a quarterly dividend on Wednesday, February 1st. Stockholders of record on Monday, February 13th will be paid a dividend of $0.01 per share on Monday, March 6th. This represents a $0.04 annualized dividend and a dividend yield of 0.19%. The ex-dividend date is Friday, February 10th.
Read our dividend analysis for CLB
.

Is Core Laboratories a good dividend stock?

Core Laboratories (NYSE:CLB) pays an annual dividend of $0.04 per share and currently has a dividend yield of 0.20%. The dividend payout ratio is 9.76%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CLB will have a dividend payout ratio of 3.67% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CLB.

What guidance has Core Laboratories issued on next quarter's earnings?

Core Laboratories updated its first quarter earnings guidance on Wednesday, February, 1st. The company provided earnings per share guidance of $0.14-0.19 for the period, compared to the consensus earnings per share estimate of $0.18. The company issued revenue guidance of $125-129 million, compared to the consensus revenue estimate of $127.42 million.

What is David M. Demshur's approval rating as Core Laboratories' CEO?

60 employees have rated Core Laboratories Chief Executive Officer David M. Demshur on Glassdoor.com. David M. Demshur has an approval rating of 36% among the company's employees. This puts David M. Demshur in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Core Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX), Intel (INTC), Netflix (NFLX), AT&T (T) and Gilead Sciences (GILD).

What is Core Laboratories' stock symbol?

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Who are Core Laboratories' major shareholders?

Core Laboratories' stock is owned by many different institutional and retail investors. Top institutional investors include Ariel Investments LLC (20.92%), Fred Alger Management LLC (8.31%), Earnest Partners LLC (7.71%), Boston Trust Walden Corp (4.25%), Van ECK Associates Corp (2.15%) and Congress Asset Management Co. MA (1.54%).
View institutional ownership trends
.

How do I buy shares of Core Laboratories?

Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Core Laboratories' stock price today?

One share of CLB stock can currently be purchased for approximately $20.75.

How much money does Core Laboratories make?

Core Laboratories (NYSE:CLB) has a market capitalization of $967.57 million and generates $489.73 million in revenue each year. The oil and gas company earns $19.45 million in net income (profit) each year or $0.41 on an earnings per share basis.

How many employees does Core Laboratories have?

The company employs 3,600 workers across the globe.

How can I contact Core Laboratories?

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The official website for the company is www.corelab.com. The oil and gas company can be reached via phone at (120) 420-3191 or via email at investor.relations@corelab.com.

This page (NYSE:CLB) was last updated on 3/21/2023 by MarketBeat.com Staff